Positive topline phase III results show Roche's Vabysmo improved vision for people living with retinal vein occlusion (RVO) October 27, 2022October 27, 2022 by / Share This.....LinkedinTwitterFacebookGoogleEmailRelated News: New phase III data show Roche’s Vabysmo rapidly…New two-year data for Roche’s Vabysmo and Susvimo…New two-year data for Roche’s Vabysmo and Susvimo…The Lancet publishes studies showing Roche’s…The Lancet publishes studies showing Roche’s…Roche’s Vabysmo prefilled syringe (PFS) approved in…
